Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "SGR"

How to Survive MACRA

Kelly Tyrrell  |  April 19, 2017

The year 2015 brought the end of the much-maligned Sustainable Growth Rate (SGR), sometimes known as the “doc fix.” The SGR established limits on Medicare reimbursement for physicians, and each year, physicians and those lobbying on their behalf were forced to stave off drastic cuts to their payments. “The SGR was Congress’s attempt to control…

Medicare Access and CHIP Reauthorization Act of 2015: What You Should Know

Joan M. Von Feldt, MD, MSEd, FACR, FACP  |  April 15, 2016

There is no denying that the past few years have been a time of immense change in healthcare. Sweeping pieces of legislation have fundamentally altered the way we practice medicine. This is absolutely the case when it comes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, for short). MACRA is an enormous…

Congress Can Begin Work to Advance Rheumatology Before New Year

Staff  |  December 1, 2014

Medicare Advantage plans, specialty tier drug spending, SGR repeal, biomedical research funding issues on lawmakers’ plates

Update on Legislation, Advocacy Efforts to Advance Rheumatology

Joseph Flood, MD  |  September 1, 2014

Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

ACR Aims to Keep Rheumatology on Congressional Radar in 2014

Staff  |  January 1, 2014

Ongoing advocacy by the ACR will target repealing SGR legislation, halting the implementation of ICD-10 coding and billing changes, and enlisting support for the Patients’ Access to Treatments Act

President’s Perspective: ACR Addresses Reform of Sustainable Growth Rate Formula

Joseph Flood, MD  |  December 1, 2013

The College’s multi-pronged plan to replace flawed SGR payment system requires continued support from rheumatologists, healthcare professionals

Continued Congressional Lobbying by ACR Volunteers Needed to Repeal SGR

Staff  |  October 1, 2013

Ways you can advocate for legislation to replace the Medicare Sustainable Growth Rate formula

SGR Fix Finally on the Horizon?

Richard Quinn  |  September 10, 2013

By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)

Much at Stake for Rheumatology in Lame Duck Session of Congress

Staff  |  December 1, 2012

Massive mandatory spending cuts—including a near 30% cut to Medicare physician reimbursement—are scheduled to go into effect in January

Why We Are Advocates

James R. O’Dell, MD  |  September 5, 2012

Rheumatology advocacy efforts are paying off in 2012.

  • 1
  • 2
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences